Stock AARTIDRUGS AARTI DRUGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Aarti Drugs Limited NSE India S.E.

Equities

AARTIDRUGS

INE767A01016

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 03:41:54 29/05/2024 pm IST 		5-day change 1st Jan Change
485.8 INR -2.01% Intraday chart for Aarti Drugs Limited -1.96% -0.71%
06/05 Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024
03/05 Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Business Summary

Aarti Drugs Limited is an India-based company that is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole and ofloxacin, among others. Its specialty chemicals products include benzene sulphonyl chloride and methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include itraconazole, fluconazole, dabigatran, ticagrelor, sitagliptin and alpha lipoic acid. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SPA.

Number of employees: 1,003

Sales per Business

INR in Million2022Weight2023Weight Delta
Active Pharmaceutical Ingredients, Pharma Intermediate, Specialty Chemicals Formulations
100.0 %
24,886 100.0 % 27,161 100.0 % +9.14%

Sales per region

INR in Million2022Weight2023Weight Delta
India
60.6 %
15,663 62.9 % 16,446 60.6 % +5.00%
International
39.4 %
9,223 37.1 % 10,714 39.4 % +16.16%

Managers

Managers TitleAgeSince
Prakash Moreshwar Patil CEO
 Chief Executive Officer 76 05/85/05
Adhish P. Patil DFI
 Director of Finance/CFO 41 06/12/06
Rushikesh Deole CMP
 Compliance Officer - 23/19/23
Rashesh Chandrakant Gogri BRD
 Director/Board Member 49 01/12/01
Harshit Manilal Savla BRD
 Director/Board Member 61 02/87/02

Members of the board

Members of the board TitleAgeSince
Prakash Moreshwar Patil CEO
 Chief Executive Officer 76 05/85/05
Harshit Manilal Savla BRD
 Director/Board Member 61 02/87/02
Harit Pragji Shah BRD
 Director/Board Member 60 15/95/15
Rashesh Chandrakant Gogri BRD
 Director/Board Member 49 01/12/01
Chandrakant V. Gogri BRD
 Director/Board Member 77 -
Uday Moreshwar Patil BRD
 Director/Board Member 60 18/00/18
Neha Rajen Gada BRD
 Director/Board Member 48 09/22/09
Ankit Vikram Paleja BRD
 Director/Board Member 40 13/21/13
Narendra Jagannath Salvi BRD
 Director/Board Member 59 25/20/25
Bhaskar Narayan Thorat BRD
 Director/Board Member - 09/22/09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 91,935,000 33,671,288 ( 36.63 %) 0 36.63 %

Shareholders

NameEquities%Valuation
Prakash Moreshwar Patil
9.238 %
8,493,205 9.238 % 51 M ₹
DSP Asset Managers Pvt. Ltd.
5.105 %
4,693,740 5.105 % 28 M ₹
Harshit Manilal Savla
4.739 %
4,357,019 4.739 % 26 M ₹
Rashesh Chandrakant Gogri
4.647 %
4,271,964 4.647 % 26 M ₹
Priti Prakash Patil
4.403 %
4,047,669 4.403 % 24 M ₹
Seema Harshit Savla
3.839 %
3,529,511 3.839 % 21 M ₹
Gogri Finserv Pvt Ltd.
3.827 %
3,518,025 3.827 % 21 M ₹
Hetal Gogri Gala
3.055 %
2,808,997 3.055 % 17 M ₹
Harit Pragji Shah
2.692 %
2,474,933 2.692 % 15 M ₹
Anushakti Enterprise Pvt Ltd.
2.623 %
2,411,374 2.623 % 15 M ₹

Company contact information

Aarti Drugs Ltd.

Mahendra Industrial Estate Road No. 29, Sion (East)

400022, Mumbai

+91 22 2401 9025

http://www.aartidrugs.co.in
address Aarti Drugs Limited(AARTIDRUGS)

Group companies

NameCategory and Sector
Pinnacle Life Science Pvt Ltd.
Logo Pinnacle Life Science Pvt Ltd.

Pinnacle Life Science Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Aarti Drugs Ltd., Pinnacle Life Science Pvt Ltd. is an Indian company that manufactures and distributes tablets, capsules, syrups, suspension, ointments and creams. The company is based in Mumbai, India.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Aarti Drugs Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
494.6 INR
Average target price
542 INR
Spread / Average Target
+9.59%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.59% 727B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.89% 347B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.66% 319B
ABBVIE INC. Stock AbbVie Inc.
+0.24% 274B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.21% 238B
NOVARTIS AG Stock Novartis AG
+7.16% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-6.18% 203B
AMGEN INC. Stock Amgen Inc.
+4.23% 161B
PFIZER, INC. Stock Pfizer, Inc.
-1.70% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AARTIDRUGS Stock
  4. AARTIDRUGS Stock
  5. Company Aarti Drugs Limited